Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Herpes simplex 1 virus-thymidine kinase and truncated low affinity nerve growth factor receptor transfected donor lymphocytes

EU orphan designation number: EU/3/03/168   
Active ingredient: Herpes simplex 1 virus-thymidine kinase and truncated low affinity nerve growth factor receptor transfected donor lymphocytes
Indication: Adjunctive treatment in hematopoietic cell transplantation
Sponsor: MolMed S.p.A.
Via Olgettina 58, I-20132 Milano, Italia
EU Centralised marketing authorisation: A centralised EU marketing authorisation has been obtained under the name Zalmoxis on with the number EU/1/16/1121

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
23/10/2003 Orphan designation EMEA/OD/041/03 (2003)3952 of 20/10/2003